Real-time reading in mammography breast screening;Screening mammografico con lettura in "tempo reale"

Radiologia Medica

Volumn 112, Issue 2, 2007, Pages 287-303

  Mariotto, R ^a,e   Brancato, B ^b   Bonetti, F ^c   Manfrin, E ^c   Strabbioli, M ^a   Mercanti, A ^c   Falsirollo, F ^a   Bricolo, P ^a   Pistolesi, G F ^d  

^a Ospedale Marzana   (Italy)

^b Unità Operativa di Senologia del C S P O   (Italy)

^c UNIVERSITY OF VERONA   (Italy)

^d Professore Emerito di Radiologia Della Università   (Italy)

^e CARLO POMA HOSPITAL   (Italy)

Author keywords

Mammography breast screening; Real time reading

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; BENIGN TUMOR; BREAST CANCER; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER SCREENING; DIAGNOSTIC IMAGING; FEMALE; HISTOPATHOLOGY; HOSPITAL; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALIGNANT NEOPLASTIC DISEASE; MAMMOGRAPHY; NEEDLE BIOPSY; PREVALENCE; SCREENING TEST; SENSITIVITY AND SPECIFICITY; SURGICAL TECHNIQUE; VACUUM ASPIRATION; VALIDATION PROCESS;

BIOPSY; BREAST NEOPLASMS; FEMALE; HUMANS; ITALY; MAMMOGRAPHY; MASS SCREENING; NEOPLASM STAGING; SENSITIVITY AND SPECIFICITY;

EID: 33947524060     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11547-007-0142-8     Document Type: Article

References (46)

1. Giorgi D, Giordano L, Ventura L et al (2004) Lo screening mammografico in Italia: survey 2003-2004. In: Zappa M, Rosselli Del Turco M (eds) Osservatorio Nazionale per la Prevenzione dei Tumori Femminili - Quarto Rapporto. Lega It Lotta Tumori, Gruppo It Screening Cervicarcinoma (GISCi), Gruppo It Screening Mammografico (GISMa), Firenze, pp 16-27
2. UK trial of early detection of breast cancer group (1988) First results on mortality reduction in the UK trial of early detection of breast cancer. Lancet 20:411-418
3. Brekelmans CTM, Collette HJA, Collette C et al (1992) Breast cancer after negative screen: follow-up of women participating in the DOM screening programme. Eur J Cancer 28A:893-895
4. Moss SM, Michel M, Patnick J et al (1995) Results from the NHS breast screening programme 1990-1993. J Med Screen 2:186-190
5. Otten JD, van Dijck JA, Peer PG et al (1996) Long term breast cancer screening in Nijmegen, The Netherlands: the nine rounds from 1975-92. J Epidemiol Community Health 50:353-358
6. Robinson JI, Crane CEB, King JM et al (1996) The South Australian Breast XRay Service: results from a statewide mammographic screening programme. Br J Cancer 73:837-842
7. Jones RD, McLean L, Young JR et al (1996) Proportion of cancers detected at the first incident screen wich were false negative at the prevalent screen. Breast 5:339-343
8. Bleyen L, van Landeghem P, Pelfrene E et al (1998 Aug) Screening for breast cancer in Ghent, Belgium: first results of a programme involving the existing health services. Eur J Cancer 34:1410-1414
9. Zappa M, Falini P, Bonardi R et al (2002) Monitoring interval cancers in mammographic screening: the Florence District programme experience. Breast 11:301-305
10. Vejborg I, Olsen AH, Jensen M-B et al (2002) Early outcome of mammography screening in Copenhagen 1991-99. J Med Screen 9:115-119
11. Verbeek ALM, Broeders MJM (2003) Evaluation of The Netherlands breast cancer screening programme. Ann Oncol 14:1203-1205
12. Hofvind S, Wang H, Thoresen S (2004) Do the results of the process indicators in the Norwegian breast cancer screening program predict future mortalità reduction from breast cancer? Acta Oncol 43:467-473
13. Törnberg S, Codd M, Rodrigues V et al (2005) Ascertainment and evaluation of interval cancers in population-based mammography screening programmes: a collaborative study in four European centres. J Med Screen 12:43-49
14. Peeters PHM, Verbeek ALM, Hendriks JHCLK et al (1989) The occurence of interval cancers in the Nijmegen screening programme. Br J Cancer 59:929-932
15. Sarkeala T, Anttila A, Saarenmaa I, Hakama M (2005) Validity of process indicators of screening for breast cancer to predict mortality reduction. J Med Screen 12:33-37
16. Alexander FE, Anderson TJ, Brown HK et al (1994) The Edimburgh randomised trial of breast cancer screening: results after 10 years of follow-up. Br. J. Cancer 70:542-548
17. Tabar L, Fagerberg G, Chen HH et al (1995) Efficacy of breast cancer screening by age. New results from the Swedish Two-County Trial. Cancer 75:2507-2517
18. Dean PB and Pamilo M for the Mammography Working Group, Radiological Society of Finland (1999) Screening mammography in Finland - 1.5 million examinations with 97 percent specificity. Acta Oncologica Suppl 13:47-54
19. National Evaluation Team for Breast cancer screening in the Netherlands (NETB). Fracheboud J, de Koning HJ, Boer R et al (2001) Nationwide breast cancer screening programme fully implemented in the Netherlands. Breast 10:6-11
20. Wagnon MC, Nagoda-Nicklewicz H, Scharpantgen A (2003) Evaluation des cancers d'intevalle du programme mammographie au Grand-Duché de Luxemburg, période: 1995-1999 (resultats définitifs) et de janvier 2000 au 31 août 2002 (résultats préliminaires). J Le Sein 13:169-177
21. Ciatto S, Ambrogetti D, Bonardi R et al (2005) Second reading of screening mammograms increases cancer detectio and recall rates. Results in the Florence screening programme. J Med Screen 12:103-106
22. Day NE, Williams DRR, Khaw KT (1989) Breast cancer screening programmes: the development of a monitoring and evaluation system. Br J Cancer 59:954-958
23. Duffy SW, Tabar L, Fagerberg G et al (1991) Breast screening, prognostic factors and survival - results from the Swedish two county study. Br J Cancer 64:1133-1138
24. Carter LC, Allen C, Henson DE (1989) Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases. Cancer 63:181-187
25. Broeders M, Codd M, Nyström L et al (2001) Epidemiological guidelines for quality assurance in breast cancer screening. In: Perry N, Broeders M, de Wolf C, Tornberg S (eds) European guidelines for quality assurance in mammography screening, 3rd edn. Europe Against Cancer - EUREF, Luxembourg, pp 15-66
26. Ikeda DM, Andersson I, Wattsgard C et al (August 1992) Interval carcinomas in the Malmö mammographic screening trial: radiographic appearance and prognostic considerations. AJR Am J Roentgenol 159:287-294
27. Van Dijck JAAM, Verbeek ALM, Hendriks JHCL et al (1993) The current detectability of breast cancer in a mammographic screening program. A review of the previous mammograms of interval and screen-detected cancers. Cancer 72:1933-1938
28. Brekelmans CTM, Peeters PHM, Faber JAJ el al (1994) The epidemiological profile of women with an interval cancer in the DOM screening programme. Breast Cancer Res Treat 30:223-232
29. Simpson W, Neilson F, Young JR, the Northern Region Breast Screening Radiology Audit Group (1995) The identification of false negatives in a population of interval cancers: a method for audit of screening mammography. Breast 4:183-188
30. Ciatto S, Rosselli Del Turco M, Zappa M (1995) The detectability of the breast cancer by screening mammography. Br J Cancer 71:337-339
31. Burrell HC, Sibbering DM, Wilson ARM et al (1996) Screening interval breast cancers: mammographic features and prognostic factors. Radiolgy 199:811-817
32. Sylvester PA, Kutt E, Baird A et al (1997) Rate and classification of interval cancers in the breast screening programme. Ann R Coll Surg Engl 79:276-277
33. Britton PD, McCann J, O'Driscoll DO et al (2000) Interval cancer peer review in East Anglia: implications for monitoring doctors as well as the NHS breast screening programme. Clinical Radiology 56:44-49
34. Taylor R, Supramaniam R, Rickard M et al (2000) Interval breast cancers in New South Wales, Australia, and 35 comparisons with trials and other mammographic screening programmes. J Med Screen 9:20-25
35. Burani R, Caimi F, Maggioni C et al (2005) Controllo di qualità del programma screening mammografico nella Azienda Sanitaria Locale Provincia Milano 1 - Analisi dei carcinomi di intervallo e discussione delle possibili cause di errore diagnostico. Radiol med 109:260-267
36. Vettorazzi M, Stocco C, Chirico A et al (2006) Quality control of mammography screening in the Veneto Region. Evaluation of four programs at Local Health Unit level - Analysis of the frequency and diagnostic pattern of interval cancers. Tumori 92:1-5
37. Tabar L, Fagerberg G, Day NE et al (1987) What is the optimum interval between mammographic screening examinations? An analysis based on the latest results of the Swedish two-county breast screening programme. Br J Cancer 59:929-932
38. Day NE, Mc Cann J, Camilleri-Ferrante C et al (1995) On behalf of the Quality Assurance Management Group of the East Anglia Breast Screening Programme. Monitoring interval cancers in breast screening programmes. J Med Screen 2:180-185
39. Everington D, Gilbert FJ, Tyack C et al (1999) The Scottish breast screening programme's experience of monitoring interval cancers. J Med Screen 6:21-27
40. Mammographic screening Evaluation group, HS Copenhagen Hospital Corporation (1999) Mammographic screening for breast cancer in Copenhagen. April 1991-March 1997. Acta Pathol Microbiol Immunol Scand 106(Suppl 83):210-224
41. Fracheboud J, de Koning HJ, Beemsterboer PMM et al (1999) Interval cancers in the Dutch breast cancer screening programme. Br J Cancer 81:912-917
42. Strax F, Venet L, Shapiro S (1973) Value of mammography in reduction of mortality from breast cancer in mass screening. AJR Am J Roentgenol 117:686-689
43. Thurfjell EL, Lernfvall KA, Taube AS et al (1994) Benefit of independent double reading in a population-based mammography screening program. Radiology 191:241-244
44. Ghate SV, Scott Soo M, Baker JA et al (2005) Comparison of recall and cancer detection rates for immediate versus batch interpretation of screening mammograms. Radiology 235:31-35
45. Gazzetta Ufficiale Unione Europea (2003/878/CE) Raccomandazione del Consiglio, 2.12.2003
46. Di Maggio C, Fioretti P, La Grassa M et al (2001) Screening mammografico o diagnostica clinica? Proposta di un modello unificato. Radiol med 101:326-333